asal smelling traditional Chinese medicine as a therapy for primary immune thrombocytopenia
- Conditions
- Primary immune thrombocytopenia
- Registration Number
- ITMCTR2000003445
- Lead Sponsor
- Jiaozuo People's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Subjects who meet the diagnostic criteria of Chinese expert consensus on diagnosis and treatment of adult primary immune thrombocytopenia (2016 Edition);
2. Subjects aged 14 years and <= 70 years;
3. Subjects without severe organ dysfunction;
4. Those who have no allergic history to this group of drugs;
5. Each subject (or his / her legal representative) must sign an informed consent form indicating that he / she understands the purpose and procedure of the study and is willing to participate in the study.
1. Patients diagnosed with malignant diseases other than ITP who need to receive treatment recently or in the near future;
2. Patients with severe liver and kidney function and cardiopulmonary dysfunction, patients with coronary heart disease, hypertension and mental illness;
3. Patients who had undergone cardiac bypass surgery and transplantation, and patients within 1 month after various operations;
4. Patients with severe bleeding or menstrual period, pregnancy and lactation period;
5. Patients with uncontrolled or severe infection;
6. Patients with intractable or severe constipation;
7. Patients who can not cooperate with the therapy;
8. Patients or family members request to withdraw from the trial.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding Score;Platelet count;
- Secondary Outcome Measures
Name Time Method Adverse reaction;